Your email will ensure Council is aware Viral Hepatitis Initiative funding is critical to the communities at risk for Hep B and C in NYC, who have also been hit hardest by the global coronavirus pandemic.
Submit written testimony or testify via Zoom at the March 15 New York City Council Health Committee Hearing on the Mayor’s Preliminary Budget. Register to testify at least 24 hours before the hearing.
Organizations wishing to receive City Council funding in FY 2022 must complete Discretionary Funding application by February 19, 2021.
NYC Council established the Viral Hepatitis Initiative in 2014, to fund community organizations to provide hepatitis B and C prevention, linkage to care and care services.
NYS Medicaid FFS removed prior authorizations for first time direct acting antivirals (DAAs) treatment of Hep C infection and for re-treatment within one year for any reason.
The Hepatitis A, B and C in NYC: 2019 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
The NYS Viral Hepatitis Strategic Plan outlines a coordinated, comprehensive, and systematic approach that will decrease the incidence and reduce the morbidity and mortality of viral hepatitis.
In response to the COVID-19 pandemic, CMS expanded payment for telehealth services so that Medicare beneficiaries can get convenient and high-quality care from the comfort of their home while avoiding unnecessary exposure to the COVID-19 virus. CMS is now reviewing the temporary ...
Opportunity to comment on letter by a group of clinical providers working to promote policy changes that have the potential to improve capacity to treat hepatitis C in Opioid Treatment Programs in New York State.
Send an email to your New York City Council Member to ask them to refund the Viral Hepatitis Initiative in FY21!
